NCT05478382View on ClinicalTrials.gov

Pregabalin is an Effective Treatment for Acute Postoperative Pain Following Spinal Surgery Without Major Side Effects

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

October 31, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Postoperative PainPregabalinSpine SurgeryAdverse Reaction to Pregabalin
Interventions
DRUG

Pregabalin 25 MG

Patients are given 0 to 3 capsules per administration according to their allocated group.

DRUG

Placebo

Patients are given 0 to 3 capsules per administration according to their allocated group.

Sponsors

Collaborators (1)

HK inno.N Corporation
All Listed Sponsors
collaborator

HK inno.N Corporation

INDUSTRY

lead

Ajou University School of Medicine

OTHER